摘要 |
Herpesvirus preparations, e.g. cultured HSV type 2, e.g. genetically disabled virus for vaccine use, can be purified, e.g. for subsequent pharmaceutical formulation, with solid phase affinity reagents containing sulphate- or sulphonate-comprising binding groups, e.g. sulphated polysaccharide groups, e.g. heparin or dextran sulphate, and eluting e.g. with salt solutions. The process can be combined with other culture and harvesting steps. |
申请人 |
CANTAB PHARMACEUTICALS RESEARCH LIMITED;JOHNSTON, MICHAEL, DENIS;O'KEEFFE, RODERIC, SIMON;SLATER, NIGEL, KENNETH, HARRY |
发明人 |
JOHNSTON, MICHAEL, DENIS;O'KEEFFE, RODERIC, SIMON;SLATER, NIGEL, KENNETH, HARRY |